CTSB and proximal spinal muscular atrophy: Taken together, our data demonstrate that the cysteine protease inhibitors, Z-FA-FMK and E64d, can significantly inhibit spinal motor neuron loss and elongate the life span of SMNΔ7 mice, serving as potential therapeutic agents for SMA patients.